Features of Tuberous Sclerosis Onset: Clinical Case

Background. Tuberous sclerosis is an orphan disease. Its rare incidence, low awareness of pediatricians, diversity in clinical signs, inheritance features — all together it complicates its diagnosis and requires multidisciplinary approach. The life of any family with a child suffering from tuberous sclerosis can be challenging, such as: diagnosis itself and its acceptance, issues with optimal management, possible disease progression, complications development. Clinical case description. This article describes a clinical case of tuberous sclerosis, as a severe multisystem disease, newly diagnosed in a child at the age of 5 months. Changes in the kidneys were presented as hypodense area in the right kidney parenchyma and were revealed in utero at 20–21 weeks of gestation. Moderate proteinuria (0.25 g/L) was noted in the early neonatal period. Ultrasound examination has shown polycystic kidney disease with multiple small cysts in both kidneys. The child was diagnosed epilepsy at the age of 5 months confirmed by electroencephalography. Brain MRI has revealed primary signs of tuberous sclerosis: cortical tubers, subependymal nodes, subependymal giant cell astrocytoma. It turned out that the girl's father had skin and kidney symptoms typical for tuberous sclerosis according to family medical history. The family was consulted by geneticist, however, parents have refused to perform molecular genetic testing. The diagnosis was clinically established based on the presence of more than two primary signs as well as additional secondary sign (multiple kidney cysts) according to the International Clinical Consensus Conference on Tuberous Sclerosis criteria. Thus, low incidence and phenotype variability in every patient, as well as the refusal to fully examine the child significantly complicates this pathology diagnosis and understanding further prognosis regarding the patient's life expectancy and its quality. Conclusion. The described clinical case demonstrates how difficult it is for the family to adapt to the fact that their child has genetic disease.

1. Tuberoznyi skleroz. Diagnostika i lechenie. Altunina GE, Balayan IG, Belousova ED, et al.; Dorofeeva MYu, ed. Moscow: Adare; 2017. (In Russ).

2. Dorofeeva MIu, Belousova ED, Pivovarova AM. Recommendations for diagnosis and treatment of tuberous sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(3):58–74. (In Russ).

3. Belousova ED, Dorofeeva MIu, Pivovarova AM, Katusheva OV. Diagnosis of tuberous sclerosis complex. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(10):89–95. (In Russ).

4. Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49(4):243–254. doi: https://doi.org/10.1016/j.pediatrneurol.2013.08.001

5. Krueger DA, Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):255–265. doi: https://doi.org/10.1016/j.pediatrneurol.2013.08.002

6. Henske EP, Jóźwiak S, Kingswood JC, et al. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;2:16035. doi: https://doi.org/10.1038/nrdp.2016.35

7. Webb DW, Osborne JP. Tuberous sclerosis. Arch Dis Child. 1995;72(6):471–474. doi: https://doi.org/10.1136/adc.72.6.471

8. National Organization for Rare Disorders. Tuberous sclerosis. In: NORD: National Organization for Rare Disorders. Available online: https://rarediseases.org/rare-diseases/tuberous-sclerosis. Accessed on November 6, 2020.

9. Rakowski SK, Winterkorn EB, Paul E, et al. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int. 2006;70(10):1777–1782. doi: https://doi.org/10.1038/sj.ki.5001853

10. Notaro K, Pierce B. Tuberous sclerosis complex: A multisystem disorder. JAAPA. 2021;34(3):28–33. doi: https://doi.org/10.1097/01.JAA.0000733220.26720.62

11. DiMario FJ Jr, Sahin M, Ebrahimi-Fakhari D. Tuberous Sclerosis Complex. Pediatr Clin North Am. 2015;62(3):633–648. doi: https://doi.org/10.1016/j.pcl.2015.03.005

12. Portocarrero LKL, Quental KN, Samorano LP, et al. Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol. 2018;93(3):323–331. doi: https://doi.org/10.1590/abd1806-4841.20186972

13. Arredondo KH, Jülich K, Roach ES. Tuberous sclerosis complex: Diagnostic features, surveillance, and therapeutic strategies. Semin Pediatr Neurol. 2024;51:101155. doi: https://doi.org/10.1016/j.spen.2024.101155

14. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657–668.

15. Bissler JJ, Batchelor D, Kingswood JC. Progress in Tuberous Sclerosis Complex Renal Disease. Crit Rev Oncog. 2022;27(2): 35–49. doi: https://doi.org/10.1615/CritRevOncog.2022042857

16. Curatolo P, Maria BL. Tuberous sclerosis. Handb Clin Neurol. 2013;111:323–331. doi: https://doi.org/10.1016/B978-0-444-52891-9.00038-5

17. Northrup H, Aronow ME, Bebin EM, et al. Updated International Tuberous Sclerosis Complex Consensus Group. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021;123:50–66. doi: https://doi.org/10.1016/j.pediatrneurol.2021.07.011

18. Morrison PJ. Tuberous sclerosis: epidemiology, genetics and progress towards treatment. Neuroepidemiology. 2009;33(4): 342–343. doi: https://doi.org/10.1159/000254570

19. Benito AE, Arreguin FE, Almazan BO, et al. Subependymal giant cell astrocytoma in pediatric patients with tuberous sclerosis complex treated with mTOR inhibitors: One center experience. Journal of Clinical Oncology. 2016; 34:e22001–e22001.

20. Major P. Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex. Aging (Albany NY). 2011;3(3):189–191. doi: https://doi.org/10.18632/aging.100298

21. Belousova ED, Vlodavets DV, Pivovarova AM, et al. Targeted therapy for tuberous sclerosis complex. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2016;61(5):106–112. (In Russ). doi: https://doi.org/10.21508/1027-4065-2016-61-5-106-112